# M3-20M (A Large-Scale Multi-Modal Molecule Dataset for AI-driven Drug Design and Discovery)

## üìä Benchmark Details

**Name**: M3-20M (A Large-Scale Multi-Modal Molecule Dataset for AI-driven Drug Design and Discovery)

**Overview**: This paper introduces M3-20M, a large-scale Multi-Modal Molecule dataset that contains over 20 million molecules, designed to support AI-driven drug design and discovery, integrating one-dimensional SMILES, two-dimensional molecular graphs, three-dimensional molecular structures, physicochemical properties, and textual descriptions.

**Data Type**: multimodal

**Domains**:
- Healthcare
- Natural Language Processing

**Languages**:
- English

**Resources**:
- [GitHub Repository](https://github.com/bz99bz/M-3)

## üéØ Purpose and Intended Users

**Goal**: To provide an extensive and diverse dataset that enhances model training and supports various downstream drug design and discovery tasks.

**Target Audience**:
- ML Researchers
- Domain Experts
- Pharmaceutical Researchers

**Tasks**:
- Molecule Generation
- Molecular Property Prediction

**Limitations**: N/A

## üíæ Data

**Source**: Integrated from existing molecular databases and partially generated by large language models like GPT-3.5.

**Size**: Over 20 million molecules

**Format**: N/A

**Annotation**: Data is annotated through integration with existing databases and generated descriptions via LLMs.

## üî¨ Methodology

**Methods**:
- Human evaluation
- Automated metrics

**Metrics**:
- Validity
- Uniqueness
- Novelty
- Mean Absolute Error (MAE)

**Calculation**: Metrics calculated through comparison of generated molecules against existing benchmarks and evaluation metrics.

**Interpretation**: Higher validity percentage indicates a higher rate of chemically correct molecules, while uniqueness and novelty measure the diversity and originality of the generated molecules respectively.

**Baseline Results**: N/A

**Validation**: Extensive experiments show significant improvements in model performance when utilizing M3-20M.

## ‚ö†Ô∏è Targeted Risks

**Risk Categories**:
- Bias
- Safety
- Privacy
- Robustness
- Accuracy

**Atlas Risks**:
No specific atlas risks defined

**Demographic Analysis**: N/A

**Potential Harm**: N/A

## üîí Ethical and Legal Considerations

**Privacy And Anonymity**: Not Applicable

**Data Licensing**: Openly accessible under the GNU General Public License v3.0.

**Consent Procedures**: Not Applicable

**Compliance With Regulations**: Not Applicable
